United States (US) Neurostimulation Devices Market (2025-2031) | Companies, Trends, Size & Revenue, Forecast, Industry, Share, Value, Growth, Competitive Landscape, Segmentation, Outlook, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Neurostimulation Devices Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Neurostimulation Devices Market - Industry Life Cycle

3.4 United States (US) Neurostimulation Devices Market - Porter's Five Forces

3.5 United States (US) Neurostimulation Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United States (US) Neurostimulation Devices Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic pain conditions in the US

4.2.2 Growing adoption of neurostimulation devices as an alternative to traditional pain management methods

4.2.3 Technological advancements leading to the development of more effective and minimally invasive neurostimulation devices

4.3 Market Restraints

4.3.1 High cost associated with neurostimulation devices and procedures limiting adoption rates

4.3.2 Lack of awareness among patients and healthcare providers about the benefits of neurostimulation therapy

4.3.3 Stringent regulatory requirements for the approval and commercialization of neurostimulation devices

6.1 United States (US) Neurostimulation Devices Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United States (US) Neurostimulation Devices Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United States (US) Neurostimulation Devices Market Revenues & Volume, By Internal Neuromodulation, 2021- 2031F

6.1.4 United States (US) Neurostimulation Devices Market Revenues & Volume, By External Neuromodulation (Non-Invasive), 2021- 2031F

6.2 United States (US) Neurostimulation Devices Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Neurostimulation Devices Market Revenues & Volume, By Parkinson's disease, 2021- 2031F

6.2.3 United States (US) Neurostimulation Devices Market Revenues & Volume, By Epilepsy, 2021- 2031F

6.2.4 United States (US) Neurostimulation Devices Market Revenues & Volume, By Depression, 2021- 2031F

6.2.5 United States (US) Neurostimulation Devices Market Revenues & Volume, By Dystonia, 2021- 2031F

6.2.6 United States (US) Neurostimulation Devices Market Revenues & Volume, By Pain Management, 2021- 2031F

6.2.7 United States (US) Neurostimulation Devices Market Revenues & Volume, By Other Applications, 2021- 2031F

7.1 United States (US) Neurostimulation Devices Market Export to Major Countries

7.2 United States (US) Neurostimulation Devices Market Imports from Major Countries

8.1 Patient satisfaction rates with neurostimulation therapy

8.2 Number of clinical studies demonstrating the efficacy of neurostimulation devices

8.3 Adoption rate of neurostimulation devices among healthcare providers

8.4 Average reimbursement rates for neurostimulation procedures

8.5 Number of patents filed for innovative neurostimulation technologies

9.1 United States (US) Neurostimulation Devices Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United States (US) Neurostimulation Devices Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United States (US) Neurostimulation Devices Market Revenue Share, By Companies, 2024

10.2 United States (US) Neurostimulation Devices Market Competitive Benchmarking, By Operating and Technical Parameters